Revelation Biosciences, Inc. Common Stock (NASDAQ: REVB) last traded at $0.760, down 2.56% on the session. The quote above updates while this page is open; the figures below are drawn from Revelation Biosciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
Revelation Biosciences, Inc. Common Stock trades on NASDAQ under the ticker REVB. Its market capitalisation is $3.03 million.
Valuation measures for Revelation Biosciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.03M |
|---|---|
| Enterprise value | -$6.02M |
| Price / book | 0.30 |
| Beta | 1.43 |
Trailing-twelve-month figures tagged in Revelation Biosciences, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$10.75M |
| Return on equity | -106.79% |
|---|
| Cash | $11.48M |
|---|
Range and volume for REVB over the past 52 weeks.
| 52-week high | $5.80 |
|---|---|
| 52-week low | $0.750 |
| Volume | 24.8K |
| Average volume | 39.3K |
| Previous close | $0.780 |
Invest a chosen dollar amount in Revelation Biosciences, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell REVB.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.